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Background: The Forkhead/Fox transcription factor Foxc2 is a critical regulator of osteogenesis and angiogenesis of
cells. Bone marrow mesenchymal stem cells (BMSCs) have the capacity to differentiate into osteoblasts,
chondrocytes, adipocytes, myocytes and fibroblasts. The present study investigates the role of Foxc2 overexpression
in osteogenesis and angiogenesis of BMSCs in vitro.
Methods: BMSCs were isolated from SD rat femurs and tibias, and characterized by cell surface antigen
identification and osteoblasts and adipocytes differentiation. The cells were transfected with lentiviral Foxc2
(Lv-Foxc2) or green fluorescent protein (Lv-GFP). Seventy hours later, Foxc2 expression was observed using real
time-PCR and Western blot. The transfected cells were stained with Alizarin red S or alkaline phosphatase (ALP) after
osteogenic induction. Meanwhile, the expression levels of osteocalcin (OCN), Runt-related transcription factor 2
(Runx2), vascular endothelial growth factor (VEGF) and platelet-derived growth factor-β (PDGF-β) were measured by
real time-PCR, Western blot and immunostaining.
Results: Results of cell characterization showed that the cells were positive to CD44 (99.56%) and negative to
CD34 (0.44%), and could differentiate into osteoblasts and adipocytes. Foxc2 overexpression not only increased the
numbers of mineralized nodes and ALP activity, but also enhanced the expressions of Runx2, OCN, VEGF and PDGF-
β in transfected BMSCs after osteogenic induction. The effects of Foxc2 on osteogenesis and angiogenesis were
significantly different between Lv-Foxc2 transfected BMSCs and Lv-GFP transfected BMSCs (P<0.05). In addition, the
MAPK-specific inhibitors, PD98059 and LY294002, blocked the Foxc2-induced regulation of BMSC differentiation.
Conclusions: Foxc2 gene is successfully transfected into BMSCs with stable and high expression. The
overexpression of Foxc2 acts on BMSCs to stimulate osteogenesis and angiogenesis. The effect of Foxc2 on
angiogenesis of the cells is mediated via activating PI3K and ERK.
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Bone formation is a temporally controlled, multistep
process, and the equilibrium between bone formation by
osteoblasts and bone resorption by osteoclasts is central
in the maintenance of bone integrity [1]. Both osteoblasts
and adipocytes share a common progenitor derived from
bone marrow mesenchymal stem cells (BMSCs), and
bone loss is associated with an expansion of adipose tis-
sue in bone marrow [2]. Angiogenesis is a process involv-
ing endothelial cell proliferation and migration, and* Correspondence: osteokzw1955@163.com
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reproduction in any medium, provided the orvascular tube formation; it always accompanies osteo-
blast differentiation and bone formation [3,4].
BMSCs have been a focus of research in stem cell-
based tissue engineering during the last decade. This is
due to their capacity to differentiate into osteoblasts,
chondrocytes, adipocytes, myocytes and fibroblasts.
Studies have shown that BMSCs have the potential to
promote angiogenesis, which makes them an ideal cell
type in engineering vascularized tissue [5,6]. The cells
can also differentiate into osteoblasts and contribute to
bone formation [7-9]. The osteoblast differentiation is
mediated by various signaling molecules and transcrip-
tional regulators, such as Wnt/beta-catenin, Notch and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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transcriptional factors [10,11].
Foxc2 is a member of the family of winged helix/
forkhead transcription factors and is known to be
expressed mainly in mesenchymal tissue [12]. Fox pro-
tein family members are important for a wide spectrum
of biological processes, including metabolism, develop-
ment, differentiation, proliferation, apoptosis, migration,
invasion and longevity [13]. It has been reported that
Foxc2-deficient mice display defective formation of the
aortic arches, multiple craniofacial bones and vertebral
columns, indicating an essential role of the gene in the
normal development of the axial skeleton and aortic
arches in mice [14,15]. Besides, Foxc2 inhibits white adi-
pocyte differentiation by suppressing the PPARγ-induced
adipogenic gene expression [16], and it regulates angio-
genesis by regulating the expressions of various genes in-
volved in the angiogenic process through activating their
promoters via Fox-binding elements (FBEs) [17,18]. In
addition, recent studies demonstrate that haplodeficiency
of Foxc2 may result in impaired formation of tumor blood
vessels as well as reduced tumor growth, and thereby pro-
vide evidence for the association of Foxc2 with the metas-
tasis and angiogenesis of tumors [19,20]. However, it
remains unclear how this transcription factor functions
during osteogenesis and angiogenesis.
The present study was aimed to determine the role of
Foxc2 overexpression on osteogenesis and angiogenesis
of BMSCs. The molecular mechanisms of Foxc2 tran-
scriptional regulation were also investigated.
Methods
Materials
Lentivirus packaging system, including plasmid pGC-FU,
pHelper 1.0, pHelper 2.0 and plasmid Foxc2, was pur-
chased from Shanghai GeneChem Co., China. Alizarin
red S and Oil Red O staining kits were obtained from
Winchem Industrial Co. Ltd., China. Dulbecco’s modi-
fied Eagle’s medium (DMEM) and fetal bovine serum
(FBS) were purchased from GIBIC, USA. Antibodies
against Foxc2, anti-CD44, anti-CD34 and β-actin were
bought from Santa Cruz Biotechnology, USA. Antibodies
against OCN, VEGF and PDGF-β were purchased from
Abcam, USA. Antibodies against Runx2, ERK and PI3K
were purchased from Novus, USA.
Methods
Isolation, culture, and verification of cells
Six male SD rats, weighing 150 ± 2 g, were obtained
from the Laboratory Animal Center in Medical College
of Xi’an Jiaotong University. All animal protocols
followed the recommendations and guidelines of the
National Institutes of Health and were approved by the
Animal Care and Use Committee at Xi’an JiaotongUniversity. BMSCs were isolated following the method
described in [21]. In brief, the femurs and tibias of the
rats were removed. Muscles and extraosteal tissues
were trimmed. Bone marrow cells were flushed and
centrifuged on a 1.073 g/mL Percoll density gradient
(Pharmacia, St. Louis, USA). The cells were washed
twice with PBS, seeded into 25 cm2 cell culture flasks,
and cultivated in L-DMEM supplemented with 10% FBS
and 20 mg penicillin-streptomycin/ml. Finally, the cul-
tures were incubated in a humidified atmosphere of 95%
air and 5% CO2 at 37°C. The medium was changed on
the 4th day of culture and every 3 days after that. When
the cells became subconfluent, usually after 7–10 days of
culture, cells were detached using trypsin/EDTA (0.25%
trypsin and 0.02% EDTA) (Sigma), concentrated by cen-
trifugation at 1000 rpm for 5 min and then suspended in
medium. An analysis of cell surface molecules, CD44
and CD34, was conducted on passage 3 cultures using
flow cytometry. Osteoblasts and adipocytes differenti-
ation was detected with Alizarin red S and Oil Red O
staining kits under different induction conditions.
Differentiation protocol and cell treatment
The transfected BMSCs were seeded in 24-well plates at
a density of 1×106 cells/well. Osteogenic differentiation
was induced under an osteogenic condition [DMEM
supplemented with 10% FBS, 0.1 μM dexamethasone
(Sigma), 50 μM ascorbate acid (Sigma), and 10 mM
β-glycerophosphate sodium (Sigma)] and an adipogenic
condition [DMEM supplemented with 10% FBS, 200 μM
indomethacin (Sigma), 1 μM dexamethasone, 0.5 mM
isobutyl methylxanthine (Sigma), and 0.5 μg/mL insulin
(Sigma)], respectively. For an analysis of the mechanisms
involved in Foxc2-mediated regulation of differentiation,
PD98059 (Sigma) at 20 μM and 50 μM, and LY294002
(Sigma) at 10 μM and 50 μM were added in the differen-
tiation medium.
Lentiviral production and transfection
A lentiviral vector expressing human Foxc2 and a control
vector expressing GFP were purchased from Shanghai
GeneChem Co., China. The lentiviruses were propagated
in 293T cells and the final titer of virus was 2×108 TU/ml.
The multiplicity of infection (MOI) was defined as the ra-
tio of the total number of PFU used in a particular infec-
tion to the total number of cells to be transfected.
Third-passage cells were transfected with lentivirus
vectors containing either GFP or Foxc2 overnight at
MOIs of 10, 50, 100 and 200 plaque-forming units
(PFU)/cell. The efficiency of transfection was evaluated
under a fluorescence microscope, followed by replace-
ment of the culture medium with fresh L-DMEM
supplemented with 10% FBS. Cells were used for the fol-
lowing experiments 72 hours after transfection.
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The transfected BMSCs were seeded in 96-well plates at
a density of 5× 104 cells/well and cultured for 7 days.
MTT assay (Sigma) was performed following the manu-
facturer's instructions to detect cell proliferation.
Western blot analysis
Cells were washed with cold PBS (pH 7.0) and lysed at
4°C in lysis buffer [50 mM Tris–HCl (pH 7.4), 150 mM
NaCl, 20 mM EDTA, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS, and protease inhibitors]. The
samples were heated at 95°C for 5 min and loaded on
12% SDS-PAGE gels and transferred onto methanol-
activated PVDF membranes (Millipore, Bedford, MA,
USA). After blockage with 5% nonfat milk in TBST
(Tris-buffered saline plus 0.1% Tween 20), the mem-
branes were incubated with primary antibodies against
Foxc2, OCN, Runx2, VEGF, PDGF-β, ERK, PI3K and
β-actin, followed by incubation with the corresponding
secondary antibodies. The bands were visualized by
using an ECL chemiluminescence kit (Santa Cruz, CA).
Real time-PCR analysis
Total RNA of cells was isolated using TRIZOL reagent
(Invitrogen) according to the manufacturer’s instruc-
tions. After reverse transcription reaction, template
DNA was used in gene-specific PCR for Foxc2, OCN,
Runx2, VEGF and PDGF-β. The primer sequences used
for this analysis are listed in Table 1. Glyceraldehyde
3-phosphate dehydrogenase (GAPDH) served as a
housekeeping gene. The conditions of real time-PCR
were as follows: 40 cycles at 94°C for 5 s and 60°C for 34
s. Dissociation stage was added to the end of amplifica-
tion procedure. There was no nonspecific amplification
determined by the dissolve curve.
Immunostaining
BMSCs were fixed and treated with 50 μg/ml 4, 6-
diamidino-2-phenyl-indol dihydrochlor-ide (DAPI) for
nuclear staining two weeks after transfection. The cells
were then stained with OCN, Runx2, VEGF and PDGF-β
visualized with a TRITC-conjugated secondary antibody.Table 1 Primer oligonucleotide sequences used for real time-







CXCR4 GGTCTGGAGACTATGACTCCThe primary antibodies were diluted 1:100. Controls in-
cluded staining without primary antibodies. Fluorescence
images were obtained using a fluorescence microcope
(fluoview 400, Olympus).
ALP and Alizarin red S staining
After 2 weeks of transfection, ALP staining was performed
using a ALP staining kit (Renbao, Shanghai, China) follow-
ing the procedures provided by the manufacturer, and
ALP activity was determined by the conversion of a color-
less p-nitrophenyl phosphate (Pnpp, Sigma, St. Louis,
USA ) to a colored p-nitrophenol [22]. For Alizarin red S
staining, cells were fixed in 10% formalin and stained with
2% Alizarin red S (Ph 4.0) solution.
Statistical analysis
Unless otherwise specified, results were presented as
mean ± standard deviation (SD). Statistical analysis was
performed using Student’s t-test. P<0.05 was considered
statistically significant.
Results
Characterization of rat BMSCs
CD44 and CD34 were chosen as markers flow cytome-
try. BMSCs were successfully expanded 3–4 days after
initial seeding, and rapidly expanded into colonies of
confluent spindle cells at 10–14 days. The third-passage
cells were incubated with antibodies of both CD44 and
CD34 (Figure 1A). Results showed that the cells were
positive to CD44 (99.56%) and negative to CD34
(0.44%). Matrix mineralization and fat droplet were visu-
alized 10 days after Alizarin red S staining and Oil Red
O staining (Figure 1B, C). According to the minimal cri-
teria represented by the Mesenchymal and Tissue Stem
Cell Committee of the International Society for Cellular
Therapy [23], the cultured cells were effectively BMSCs.
Foxc2 transfection
When BMSCs grew to 80% confluence, the cells were
transfected with Lv-GFP for 72 h at various MOIs (10,
50, 100 and 200). The efficiency of gene transfection was












Figure 1 Characterization of rat BMSCs. (A) The results of cell surface antigen detection showed that BMSCs were positive to CD44 (99.56%)
and negative to CD34 (0.44%). (B) The mineralization nodes were monitored by Alizarin red S staining. (C) Fat droplets formation was monitored
by Oil Red O staining.

























































Figure 2 Expression of GFP and Foxc2 genes after transfection. (A) Transfection efficiency at various MOIs (10, 50, 100 and 200) 72 hours
after transfection (×100). (B) Cell proliferation after transfection in the Lv-Foxc2 and Lv-GFP groups detected using MTT assay. (C) Foxc2 gene
expression measured by real-time PCR 72 hours after transfection. GAPDH was used as a housekeeping gene. (D) Foxc2 protein expression
evaluated by western blot 72 hours after transfection. Results were expressed as mean±SD of triplicate experiments. #p<0.01 vs. control.





























































































































Figure 3 The effect of Foxc2 on osteogenic differentiation. (A, B and C) BMSCs were transfected with Lv-GFP or Lv-Foxc2 for 2 weeks. Cells
stained with Alizarin red S (A and B, a1 presents the Lv-Foxc2 group, and a2 presents the Lv-GFP group). Cells stained with ALP (C, c1 presents
the Lv-Foxc2 group and c2 presents the Lv-GFP group). (D) ALP activities in BMSCs. (E) Expressions of CON and Runx2 mRNA detected by real-
time PCR 72 hours after transfection. The relative density of each gene was statistically analyzed. #p<0.01 vs. control. (F and G) CON and Runx2
expressions examined by Western blot 72 hours after transfection. The results were indicated by the ratio of band intensity of CON or Runx2 with
β-actin. (H) Immunostaining for OCN and Runx2 (Texas-Red) with nuclear counterstained (DAPI-blue) 2 weeks after transfection (× 400). The
results were expressed as mean±SD of triplicate experiments. #p<0.01 vs. control.
You et al. BMC Musculoskeletal Disorders 2013, 14:199 Page 5 of 10
http://www.biomedcentral.com/1471-2474/14/199
You et al. BMC Musculoskeletal Disorders 2013, 14:199 Page 6 of 10
http://www.biomedcentral.com/1471-2474/14/199fluorescence microscope. The percentages of GFP-positive
cells at different MOIs were 27.3±1.5%, 73.4±1.6%, 91.2
±1.8% and 90.8±1.5%, respectively (Figure 2A). The MTT
assay data indicated that cells overexpressing Foxc2 prolif-
erated significantly (Figure 2B).
Real time-PCR and Western blot demonstrated that
Foxc2 gene was stably expressed in cells 72 h post-
transfection (Figure 2C, D). Foxc2 expression was sig-
nificantly higher in Lv-Foxc2 transfected cells than in
Lv-GFP transfected cells (P < 0.05).
Foxc2 enhanced osteogenesis
Alizarin red S staining showed that the area of positive
staining of Lv-Foxc2 transfected cells was nearly 2.5 folds
compared with that of the Lv-GFP transfected (Figure 3A,
B). ALP expression was evidently observed in Lv-Foxc2
transfected cells after 2 weeks of induction (Figure 3C),
and the ALP activity increased to nearly three folds of
that in Lv-GFP transfected cells (Figure 3D). Similar ex-
pressions of osteoblast differentiation markers, OCN and
Runx2, were observed in the two groups of cells
(Figure 3E-H). These results demonstrated that Foxc2
overexpression enhanced osteogenesis of BMSCs.
Foxc2 regulated angiogenesis via activating ERK and PI3K
Results of real-time PCR, Western blot and immuno-
stainning showed that the angiogenic markers, VEGF
and PDGF-β, were highly expressed in Lv-Foxc2
transfected cells while rarely expressed in Lv-GFP
transfected cells (Figure 4). This suggested that Foxc2
hyper-activation might provide the transfected cells a




















Figure 4 Immunostaining for VEGF and PDGF-β (Texas-Red) with nuccellular pathways, PI3K and ERK, can modulate the
transcriptional activity of Foxc proteins in Dll4 and
Hey2 induction. To investigate the role of the two sig-
naling pathways in the regulation of angiogenesis by
Foxc2, the transfected BMSCs were induced to differen-
tiate with or without adding the inhibitors of ERK or
PI3K. The results showed that the addition of the spe-
cific inhibitor of ERK or PI3K, namely, PD98059 (20 and
50 μM) or LY294002 (10 and 50 μM), led to a decrease
in the gene expressions of VEGF and PDGF-β in cells
overexpressing Foxc2 (Figure 5A-F). This indicated that
inhibition of ERK or PI3K interfered with the regulation
of Foxc2 in BMSC differentiation.
The levels of ERK and PI3K were higher in the cells
transfected with Lv-Foxc2, indicating that Foxc2
overexpression activated the two signaling pathways in
differentiation medium, but the activation was signifi-
cantly abrogated by pre-treating cells with PD98059 or
LY294002 (Figure 6A, B).
Discussion
In this study, we demonstrate that Foxc2 overexpression
enhances osteogenesis of BMSCs and provides the cells
a major pro-angiogenetic inclination. This is consistent
with the research of Arnold Caplan, et al. [24]. Our re-
sults also show that Foxc2 plays an important regulative
role in angiogenesis via activating ERK or PI3K signaling
pathway.
The Forkhead protein Foxc2 has emerged as an im-
portant regulator of epithelial-to-mesenchymal transi-
tions (EMTs). In the execution of EMT, many genes
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Figure 5 Effect of blockade of ERK or PI3K on the expressions of angiogenic makers. Cells overexpressing Foxc2 were cultured in
osteogenic induction medium in the absence or presence of PD98059 (A, B, C) or LY294002 (D, E, F). Western blot results of VEGF or PDGF-β
expression were indicated by the ratio of band intensity of VEGF or PDGF-β with β-actin (A, B, D, E). The results were expressed as mean±SD of
triplicate experiments. Real time-PCR analysis of VEGF or PDGF-β was performed (C, F). The relative mRNA level of each gene was quantitated









































Figure 6 Foxc2 overexpression induces activation of ERK and PI3K in BMSCs. (A, B) BMSCs were transfected with Lv-GFP, Lv-Foxc2 or
Lv-Foxc2 following pretreatment with 50 μM PD98059 or 10 μM LY294002 for 1 h. Cell lysates harvested after 2 weeks of culture were analyzed
by SDS-PAGE and Western blot with anti ERK or anti-PI3K antibody. The result of ERK or PI3K expression was indicated by the ratio of band
intensity of ERK or PI3K with β-actin. *p<0.05 vs. Lv-GFP group; #p<0.01 vs. group.
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tered. The functional loss of E-cadherin in an epithelial
cell is considered a hallmark of EMT. Many EMT-
inducing transcription factors, including Snail, Slug,
dEF1, ZEB2, Twist1, Foxc2 and Goosecoid, can repress
E-cadherin directly or indirectly when overexpressed
[25]. EMT-derived cells share many properties with mes-
enchymal stem cells (MSCs), while conversely, MSCs
express some EMT-associated genes, such as Snail and
Foxc2. Similar to MSCs, EMT-derived cells can also dif-
ferentiate into mature osteoblasts, adipocytes and
chondrocytes [26]. Moreover, EMT is an important
source for the accumulation of carcinoma associated
fibroblasts [27]. It has been proved that the differenti-
ation of epithelial cells is correlated with increased levels
of cytoplasmic Foxc2, whereas the dedifferentiation is
associated with decreased Foxc2 levels [28]. However,
the function of Foxc2 in osteoblast differentiation and
angiogenesis has been rarely studied.
We have found in our study that Foxc2 is highly
expressed in BMSCs after transfection, and the Foxc2
hyperexpression promotes cell viability (Figure 2). We
also reconfirm that Foxc2 enhances the differentiation of
BMSCs into osteoblasts (Figure 3). The mechanisms of
Foxc2-regulated osteogenesis are still not completely
understood. It was reported that the activation of
canonical Wnt-β-catenin signals might be involved in
the Foxc2-mediated osteoblast differentiation [29]. In
addition, Su Jin Park et al. found that Foxc2 was a down-
stream target of well known anabolic systemic hormones
such as BMP2 and PTH, and that Foxc2 promoted
osteoblastogenesis by regulating the survival, prolifera-
tion and differentiation of osteoblasts through the up-
regulation of integrin β1 [30].
Foxc2 also plays an important role in vascular endo-
thelial development. It was reported that Foxc2 acted
upstream of Notch signaling in arterial gene expression
by directly regulating the Dll4 promoter via a Fox-
binding element [31,32]. Bone marrow-derived cells
transfected with Foxc2 caused an increased cellular mo-
bility through the up-regulation of CXCR4 [33]. This in-
crease in cellular mobility due to Foxc2 overexpression
has been experienced in other two separate studies, in
which the action of Foxc2 was linked to the regulation
of two different proteins, p120-catenin and β3 integrin
[34,35]. p120-catenin is a regulator of E-cadherin, which
promotes cell-cell adhesion at adherens junctions. Loss
of p120-catenin expression results in the destabilization
of the E-cadherin complex, which is a critical step in in-
vasion and metastasis [34]. Physiologically, Foxc2 is acti-
vated by hypoxia and VEGF. It acts on specific ligand
proteins, including p120-catenin and β3 integrin, to
destabilize them and promote cellular releasing from
their environment. It induces CXCR4 transcription,allowing cells to migrate to the site of injury or hypoxia
following a chemokine (CXCL12) gradient. High CXCR4
levels in tumors are linked to poor survival [35].
We have found that Foxc2 overexpression enhances
the expressions of angiogenic factors such as VEGF and
PDGF-β (Figures 4, 5), and increases the protein levels
of ERK and PI3K. The ERK or PI3K inhibitor, PD98059
or LY294002, attenuates the Foxc2-mediated enhance-
ment of angiogenic factors (Figures 5, 6). It has been
found that VEGF-activated PI3K and ERK pathways
modulate the transcriptional activation of Dll4 and Hey2
genes by Foxc proteins [36]. A recent research shows
that VEGF-stimulated PI3K and ERK pathways modulate
the transcriptional activity of Foxc2 for arterial gene
expression in endothelial cells [37]. Consequently, func-
tional interaction between VEGF signaling and Foxc2
may take place in some aspects of blood vessel
formation.
In most in vitro contexts, the PI3K and ERK pathways
are stimulated by VEGF together and often act in a syn-
ergistic manner. PI3K activation leads to AKT activation,
which promotes the migration and survival of endothe-
lial cells and nitric oxide production. ERK/MAPK activa-
tion promotes endothelial cell proliferation. Nonetheless,
in certain endothelial culture systems, the PI3K branch
antagonizes the ERK/MAPK branch [38]. The reasons
for the discrepancy of the functional effects of ERK and
PI3K are unclear.
MSCs, when are on a stiff substrate and in large num-
bers, tend to spontaneously differentiate over time into
osteoblasts, and this process may be speeded by the
overexpression of an important transcriptional factor,
Foxc2 [39]. However, many data suggest that the up-
regulation of Foxc2, or its transfection, leads to an in-
crease of cellular mobility often linked with progression,
invasion and angiogensis of tumor [19,20,33]. Thus, the
clinical safety of Foxc2-based therapy should still be
verified.Conclusions
Taken together, this work examines the effects of Foxc2
on the commitment of SD rat BMSCs into the osteo-
genic and angiogenic lineages in vitro. Our results
demonstrate that Foxc2 overexpression acts on the
transfected BMSCs to enhance the expressions of osteo-
genic makers and provide the cells a pro-angiogenetic
inclination. Furthermore, it is likely that ERK and PI3K
signaling pathways are involved in the Foxc2-mediated
regulation of angiogenetic inclination.
Future research on the function of Foxc2 in osteogen-
esis and angiogenesis can be conducted on some novel
cell models to study its effects on different mesenchy-
mal-related differentiation processes.
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